Upregulation of ECT2 Predicts Adverse Clinical Outcomes and Increases 5-Fluorouracil Resistance in Gastric Cancer Patients

Table 1

Relationship between ECT2 expression and clinic-pathological characteristics of GC patients.

Characteristics	Cases	ECT2		value
		High	Low
Age (years)				0.083
≥55	30	18	12
<55	36	30	6
Gender				0.124
Male	38	28	10
Female	28	20	8
Tumor size (mm)				0.095
≤5.0	26	18	8
>5.0	40	30	10
Differentiation				0.064
Well/moderate	22	16	6
Poor	44	32	12
Lymph node metastasis				0.042
Yes	42	30	12
No	24	18	6
TNM stage				0.024
I-II	22	15	7
III-IV	44	33	22